Over the past 12‑18 months the Antarctic Krill Oil market has accelerated its momentum through strategic collaborations and regulatory progress. In early 2025, Oceanic Nutrients partnered with MarineBio Labs to co‑develop a high‑purity krill phospholipid extraction platform that promises 30 % higher EPA/DHA yields. The same quarter saw KrillPure Inc. acquire Swiss‑based AlgaHealth GmbH, expanding its portfolio into combined krill‑algae omega‑3 blends. In June 2025, PureSea™ launched a patented micro‑encapsulation technology that protects sensitive omega‑3s from oxidation, enabling shelf‑stable liquid formulations. Meanwhile, the European Food Safety Authority updated its novel food assessment, granting a broader health‑claim allowance for krill‑derived phosphatidylcholine. Consumer demand has shifted toward sustainably sourced, traceable products, prompting retailers to prioritize certified supply chains. Finally, BlueWave Ventures closed a $45 million Series C round to scale production facilities in Antarctica’s protected zones, reinforcing the sector’s growth trajectory. Collectively, these moves underscore emerging Antarctic Krill Oil industry trends that favor integrated supply chains, premium bioavailability, and tighter sustainability standards.
